Cas no 364779-15-7 (Ginsenoside Rk3)
Ginsenoside Rk3 Chemical and Physical Properties
Names and Identifiers
-
- Ginsenoside Rk3 standard
- Ginsenoside Rk3
- Y0093
- CHEMBL4215641
- CS-3848
- AS-78397
- MFCD23379928
- Ginsenoside-Rk3
- AKOS030526797
- 364779-15-7
- CHEBI:228315
- HY-N0906
- (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-(6-methylhepta-1,5-dien-2-yl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
- AC-34682
- SCHEMBL18542864
- 3beta,12beta-dihydroxydammar-20(21),24-diene-3-O-beta-D-glucopyranosyl(1-2)-beta-D-glucopyranoside
- (2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-(6-methylhepta-1,5-dien-2-yl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-6-yl)oxy)-6-(hydroxymethyl)oxane-3,4,5-triol
-
- MDL: MFCD23379928
- Inchi: 1S/C36H60O8/c1-19(2)10-9-11-20(3)21-12-15-35(7)27(21)22(38)16-25-34(6)14-13-26(39)33(4,5)31(34)23(17-36(25,35)8)43-32-30(42)29(41)28(40)24(18-37)44-32/h10,21-32,37-42H,3,9,11-18H2,1-2,4-8H3/t21-,22-,23+,24-,25-,26+,27+,28-,29+,30-,31+,32-,34-,35-,36-/m1/s1
- InChI Key: AVXFIVJSCUOFNT-QXPABTKOSA-N
- SMILES: O([C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O)[C@H]1C[C@@]2(C)[C@]3(C)CC[C@H](C(=C)CC/C=C(\C)/C)[C@H]3[C@@H](C[C@@H]2[C@@]2(C)CC[C@@H](C(C)(C)[C@@H]21)O)O
Computed Properties
- Exact Mass: 620.42881887 g/mol
- Monoisotopic Mass: 620.42881887 g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 6
- Hydrogen Bond Acceptor Count: 8
- Heavy Atom Count: 44
- Rotatable Bond Count: 7
- Complexity: 1100
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 15
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 140
- Molecular Weight: 620.9
- XLogP3: 5.7
Experimental Properties
- Color/Form: Powder
- Density: 1.20±0.1 g/cm3 (20 oC 760 Torr),
- Melting Point: Not available
- Boiling Point: 722.4±60.0℃ at 760 mmHg
- Flash Point: 390.7±32.9 °C
- Solubility: Insuluble (1.2E-3 g/L) (25 oC),
- Vapor Pressure: 0.0±5.3 mmHg at 25°C
Ginsenoside Rk3 Security Information
- Signal Word:warning
- Hazard Statement: H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
-
Warning Statement:
P264Thoroughly clean after treatment
P280Wear protective gloves/Wear protective clothing/Wear protective goggles/Wear a protective mask
P305If it enters the eyes
P351Rinse carefully with water for a few minutes
P338Remove the contact lens(If any)And easy to operate,Continue flushing
P337If eye irritation persists
P313Obtain medical advice/care - Safety Instruction: H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Storage Condition:Please store the product under the recommended conditions in the Certificate of Analysis.
Ginsenoside Rk3 Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| MedChemExpress | HY-N0906-5mg |
Ginsenoside Rk3 |
364779-15-7 | 98.44% | 5mg |
¥1488 | 2025-04-16 | |
| MedChemExpress | HY-N0906-10mg |
Ginsenoside Rk3 |
364779-15-7 | 98.44% | 10mg |
¥2200 | 2025-04-16 | |
| MedChemExpress | HY-N0906-25mg |
Ginsenoside Rk3 |
364779-15-7 | 98.44% | 25mg |
¥3713 | 2025-04-16 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-IT328-1mg |
Ginsenoside Rk3 |
364779-15-7 | 98+% | 1mg |
1397CNY | 2021-05-08 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-IT328-5mg |
Ginsenoside Rk3 |
364779-15-7 | 98+% | 5mg |
3745CNY | 2021-05-08 | |
| Chemenu | CM182407-10mg |
Ginsenoside Rk3 |
364779-15-7 | 98% | 10mg |
$404 | 2021-06-15 | |
| ChemFaces | CFN92593-10mg |
Ginsenoside Rk3 |
364779-15-7 | >=98% | 10mg |
$180 | 2021-07-22 | |
| ChemScence | CS-3848-5mg |
Ginsenoside Rk3 |
364779-15-7 | 98.85% | 5mg |
$220.0 | 2022-04-27 | |
| ChemScence | CS-3848-10mg |
Ginsenoside Rk3 |
364779-15-7 | 98.85% | 10mg |
$370.0 | 2022-04-27 | |
| ChemScence | CS-3848-25mg |
Ginsenoside Rk3 |
364779-15-7 | 98.85% | 25mg |
$620.0 | 2022-04-27 |
Ginsenoside Rk3 Production Method
Production Method 1
Ginsenoside Rk3 Raw materials
Ginsenoside Rk3 Preparation Products
- Ginsenoside Rh1 (63223-86-9)
- Ginsenoside Rk3 (364779-15-7)
- Ginsenoside F1 (53963-43-2)
- beta-D-Glucopyranoside, (3beta,6alpha,12beta,20R)-3,12,20,25-tetrahydroxydammaran-6-yl (80952-73-4)
- Dammar-24-ene-3,6,12,20-tetrol; (3β,6α,12β,20R)-form, 20-Me ether, 6-O-β-D-glucopyranoside (2319608-29-0)
- ginsenoside Rh5 (340270-88-4)
- (20R)-Ginsenoside Rh1 (80952-71-2)
Ginsenoside Rk3 Related Literature
-
Xingjie Wu,Linzhu Zhou,Yue Su,Chang-Ming Dong J. Mater. Chem. B, 2016,4, 2142-2152
-
Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
-
Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
-
Piotr Szcze?niak,Sebastian Stecko RSC Adv., 2015,5, 30882-30888
Additional information on Ginsenoside Rk3
Ginsenoside Rk3 (CAS No. 364779-15-7): A Comprehensive Guide to Its Properties and Applications
Ginsenoside Rk3, with CAS number 364779-15-7, is a rare and highly bioactive compound derived from Panax ginseng. As one of the ginsenosides, it has gained significant attention in recent years due to its potential health benefits and therapeutic properties. This article delves into the chemical characteristics, pharmacological effects, and modern applications of Ginsenoside Rk3, while addressing common questions and trending topics in the field.
The molecular structure of Ginsenoside Rk3 belongs to the protopanaxadiol-type ginsenosides, characterized by its unique sugar moieties arrangement. With increasing interest in natural bioactive compounds and herbal medicine research, scientists have been exploring the mechanisms behind Ginsenoside Rk3's neuroprotective effects and anti-inflammatory properties. Recent studies published in journals like Phytomedicine and Journal of Ginseng Research highlight its potential in addressing modern health concerns.
One of the most searched topics regarding Ginsenoside Rk3 supplements relates to their potential role in cognitive health support. Current research suggests that this compound may help maintain brain function and protect against age-related cognitive decline, making it particularly relevant for aging populations. Another trending discussion point is its possible application in metabolic syndrome management, with preliminary studies indicating effects on glucose metabolism and lipid regulation.
The extraction and purification of Ginsenoside Rk3 (CAS 364779-15-7) typically involve advanced techniques such as high-performance liquid chromatography (HPLC) and preparative chromatography. These methods ensure high purity levels required for pharmaceutical research and nutraceutical applications. The compound's stability under various conditions has been extensively studied to optimize its formulation in dietary supplements and functional foods.
In the cosmetic industry, Ginsenoside Rk3 has emerged as a promising ingredient for anti-aging skincare products. Its potential to promote collagen synthesis and protect against oxidative stress aligns with the growing demand for natural anti-aging solutions. Formulators are particularly interested in its compatibility with other botanical extracts and its performance in various cosmetic delivery systems.
Quality control of Ginsenoside Rk3 raw material involves rigorous testing for identity, purity, and potency. Analytical methods such as LC-MS (Liquid Chromatography-Mass Spectrometry) are commonly employed to verify the compound's authenticity and quantify its concentration in finished products. These quality assurance measures are crucial for manufacturers developing standardized ginseng extracts and evidence-based herbal formulations.
The market for Ginsenoside Rk3 products has been expanding rapidly, driven by increasing consumer awareness of traditional medicine modernization and preventive healthcare approaches. Industry reports indicate growing demand in both North American markets and Asian markets, particularly among health-conscious consumers seeking natural alternatives to conventional therapies.
Recent advancements in biotechnological production of Ginsenoside Rk3 through plant cell culture and enzymatic biotransformation have addressed supply challenges associated with this rare compound. These innovative approaches not only improve yield but also enhance sustainability in the production of high-value ginsenosides, responding to environmental concerns in the botanical ingredient industry.
Safety evaluation studies have demonstrated favorable profiles for Ginsenoside Rk3 consumption within established dosage ranges. However, researchers emphasize the importance of clinical dose optimization and long-term safety assessment, especially for specific population groups. These considerations are particularly relevant for formulators developing targeted health products containing this bioactive compound.
Future research directions for Ginsenoside Rk3 (364779-15-7) include exploring its potential in personalized medicine applications and investigating synergistic effects with other phytochemical compounds. The scientific community is particularly interested in elucidating its molecular targets and signaling pathways, which could lead to novel therapeutic strategies for various health conditions.
For researchers and product developers seeking high-purity Ginsenoside Rk3, it's essential to source materials from reputable suppliers with comprehensive certificates of analysis and transparent manufacturing processes. Proper storage conditions, typically at controlled room temperature in protected from light containers, are crucial for maintaining the compound's stability and bioactivity over time.
The growing body of evidence supporting Ginsenoside Rk3 benefits continues to attract interest from both the scientific community and health-conscious consumers. As research progresses, this compound is poised to play an increasingly important role in integrative medicine approaches and preventive healthcare strategies, bridging traditional knowledge with modern scientific validation.
364779-15-7 (Ginsenoside Rk3) Related Products
- 142735-55-5(b-D-Galactopyranoside, (1b,3b,16b,22S)-1-(b-D-glucopyranosyloxy)-3,22-dihydroxycholest-5-en-16-yl(9CI))
- 147419-93-0(Ginsenoside Rg6)
- 139975-46-5(b-D-Galactopyranoside, (1b,3b,16b,22S)-1-[(6-deoxy-a-L-mannopyranosyl)oxy]-3,22-dihydroxycholest-5-en-16-yl 3-O-(6-deoxy-a-L-mannopyranosyl)- (9CI))
- 100187-68-6(b-D-Glucopyranoside, (3b,6b)-5,6,16-trihydroxygrayanotox-9-en-3-yl (9CI))
- 142735-53-3(b-D-Galactopyranoside, (1b,3b,16b,22S)-1,3,22-trihydroxycholest-5-en-16-yl (9CI))
- 105558-26-7(Ginsenoside Rh3)
- 139953-18-7(b-D-Galactopyranoside, (3b,16b,22S)-3,22-dihydroxycholest-5-en-16-yl 3-O-(6-deoxy-a-L-mannopyranosyl)-)
- 139953-19-8(Cholest-5-ene-3,16,22-triol; (3β,16β,22S)-form, 3-O-β-D-Glucopyranoside, 16-O-[α-L-rhamnopyranosyl-(1→3)-β-D-galactopyranoside])
- 126223-28-7(Ginsenoside Rg4)
- 186763-78-0(Ginsenoside Rg5)